979 Impact of Concomitant Immunomodulator Treatment on Efficacy and Safety of Anti-TNF Therapy in Crohn's Disease: A Meta-Analysis of Placebo Controlled Trials With Individual Patient-Level DataJennifer Jones, Corey A. Siegel, Gilaad G. Kaplan et al.|Gastroenterology|2013Cited by 19
Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groupsAdam S. Cheifetz, Corey A. Siegel, Gil Melmed et al.|Inflammatory Bowel Diseases|2012Cited by 16
Mo1934 - Gut Microbial Markers of Arthritis Including Inflammatory Bowel Disease Associated ArthropathyDavid A. Muñiz-Pedrogo, Purna Kashyap, Laura H. Raffals et al.|Gastroenterology|2018Cited by 5
Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective CohortEdward L. Barnes, Hans Herfarth, Poonam Beniwal‐Patel et al.|Crohn s & Colitis 360|2023Cited by 4
S1120 Vedolizumab Is Effective for the Treatment of Chronic Inflammatory Conditions of the Pouch in a Prospective Multicenter StudyEdward L. Barnes, Hans Herfarth, Laura H. Raffals et al.|The American Journal of Gastroenterology|2023Cited by 1